InvestorsHub Logo
Followers 32
Posts 7730
Boards Moderated 0
Alias Born 12/15/2002

Re: mrdecember123 post# 4151

Tuesday, 11/30/2021 9:57:34 AM

Tuesday, November 30, 2021 9:57:34 AM

Post# of 6113
The analyst following BABY (Cannaccord) show that Q1 revenue was $ 1,14M, $Q2 was $ 1,11M (we now know that Q3 was $ 1,17) and according to Cannaccord, Fy2021 total revenue should be $ 7,07M (means Q4 should be $ 3,65M)
Cannaccord also estimate that Fy2022 revenue should be $ 49,57.

Source: https://ca.finance.yahoo.com/quote/BABY.V/analysis/

Additionnally, as per current financials, Else Cash position was C$13.8 million and the Company had no Loans liability as of September 30, 2021.

That quick analysis could very well be what is behind Hamutal Yitzhak’s comment saying: “Else is a company that should not yet be measured solely by Quarters. We are building a pathway to be a potential global leader in the plant-based nutrition arena and aiming for a multibillion-dollar market in 5 years. We are making great strides each quarter and have achieved significant milestones in this quarter including our Walmart.com and Kroger online partnerships. We also completed the development of two new product lines, and we expect momentum to continue and accelerate throughout the remainder of the year and beyond.”

I personally have all the shares I want to have (70% of my total portfolio) and as recommended I intend to 'HOLD'. Wasn't that committed to this I would recommend 'BUY'

Patiently,

Roger